Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α.
Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, Yu X, Xiong K, Luo C, Zhu J, Wang F, Zeng Z, Pan D.
Cell Metab. 2023 Sep 5;35(9):1580-1596.e9. doi: 10.1016/j.cmet.2023.07.001. Epub 2023 Jul 27.
Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy.
Wu L, Hollinshead KER, Hao Y, Au C, Kroehling L, Ng C, Lin WY, Li D, Silva HM, Shin J, Lafaille JJ, Possemato R, Pacold ME, Papagiannakopoulos T, Kimmelman AC, Satija R, Littman DR.
Cell. 2020 Aug 6;182(3):641-654.e20. doi: 10.1016/j.cell.2020.06.014. Epub 2020 Jul 1.
Glucose-6-phosphate isomerase deficiency hemolysis.
Huang B, Ma Z, Xie T, Liu W, Xiao J, Sun J, Li B.
Quant Imaging Med Surg. 2023 Dec 1;13(12):8869-8872. doi: 10.21037/qims-22-1154. Epub 2023 Nov 13.
RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32.
Wang L, Song YY, Wang Y, Liu XX, Yin YL, Gao S, Zhang F, Li LY, Zhang ZS.
Pharmacol Res. 2023 Dec;198:106995. doi: 10.1016/j.phrs.2023.106995. Epub 2023 Nov 17.
Glucose-6-phosphate isomerase deficiency.
Kugler W, Lakomek M.
Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):89-101. doi: 10.1053/beha.1999.0059.
Hemolytic anemias and erythrocyte enzymopathies.
Valentine WN, Tanaka KR, Paglia DE.
Ann Intern Med. 1985 Aug;103(2):245-57. doi: 10.7326/0003-4819-103-2-245.
Hereditary glucosephosphate isomerase deficiency. A review.
Paglia DE, Valentine WN.
Am J Clin Pathol. 1974 Dec;62(6):740-51. doi: 10.1093/ajcp/62.6.740.
Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes.
Yang T, Sun K, Wang C, Swarnkar G, Quan S, Kress D, Xiao J, Alippe Y, Zheng H, Brophy RH, Hao D, McAlinden A, Abu-Amer Y, Shen J, Mbalaviele G.
Arthritis Res Ther. 2021 Nov 16;23(1):286. doi: 10.1186/s13075-021-02668-8.
Genetic disorders of red cell metabolism.
Beutler E.
Med Clin North Am. 1969 Jul;53(4):813-26.
Hematologically important mutations: molecular abnormalities of glucose phosphate isomerase deficiency.
Fujii H, Kanno H, Hirono A, Miwa S.
Blood Cells Mol Dis. 1996;22(2):96-7. doi: 10.1006/bcmd.1996.0014.
